RTI Surgical (RTIX) Reports In-Line Q1 EPS, Beats on Revenues; Affirms FY18 Guidance

Go back to RTI Surgical (RTIX) Reports In-Line Q1 EPS, Beats on Revenues; Affirms FY18 Guidance
RTI Biologics, Inc. (NASDAQ: RTIX) Delayed: 3.14 --0 (-0%)
Previous Close $3.14    52 Week High $4.65 
Open $41.01    52 Week Low $2.50 
Day High $3.14    P/E N/A 
Day Low $3.14    EPS $-0.34 
Volume 1,559